TESTBANK
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy-L. Wright
, TABLE OF CONTENTWQ WQ
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................4
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 2. Review of Basic Principles of Pharmacology........................................................................................5
WQ WQ WQ WQ WQ WQ WQ
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
WQ WQ WQ WQ
Chapter 4. Legal and Professional Issues in Prescribing ...................................................................................... 14
WQ WQ WQ WQ WQ WQ WQ
Chapter 5. Adverse Drug Reactions..................................................................................................................... 16
WQ WQ WQ WQ
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
WQ WQ WQ WQ WQ
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
WQ WQ WQ WQ
Chapter 8. Herbal Therapies ................................................................................................................................ 28
WQ WQ WQ
Chapter 9. Cannabis ............................................................................................................................................. 31
WQ WQ
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
WQ WQ
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................ 38
WQ WQ WQ WQ WQ WQ WQ
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
WQ WQ WQ WQ WQ WQ WQ
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................. 53
WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 14. Drugs Affecting the Respiratory System .......................................................................................... 61
WQ WQ WQ WQ WQ WQ
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
WQ WQ WQ WQ WQ WQ
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................... 69
WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 17. Drugs Affecting the Immune System: Immunomodulators .............................................................. 75
WQ WQ WQ WQ WQ WQ WQ
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
WQ WQ WQ WQ WQ WQ
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .................... 80
W
Q WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs .............................. 83
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
WQ WQ WQ WQ WQ WQ
Chapter 22. Drugs Affecting the Bones and Joints .............................................................................................. 92
WQ WQ WQ WQ WQ WQ WQ
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
WQ WQ WQ WQ WQ WQ
Chapter 24. Drugs Used to Treat Bacterial Infections.........................................................................................101
WQ WQ WQ WQ WQ WQ WQ
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..........................................................105
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................108
WQ WQ WQ WQ WQ WQ WQ
Chapter 27. Drugs Used to Treat Eye and Ear-Disorders ....................................................................................111
WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 28. Anemia ............................................................................................................................................113
WQ WQ
Chapter 29. Anxiety and Depression ..................................................................................................................116
WQ WQ WQ WQ
Chapter 30. Attention Deficit-Hyperactivity-Disorder........................................................................................120
WQ WQ WQ
Chapter 31. Asthma and Allergy ........................................................................................................................122
WQ WQ WQ WQ
Chapter 32. Chronic Obstructive Pulmonary-Disease.........................................................................................125
WQ WQ WQ WQ
Chapter 33. Contraception ..................................................................................................................................127
WQ WQ
Chapter 34. COVID-19: Acute and Chronic .......................................................................................................130
WQ WQ WQ WQ WQ
Chapter 35. Dermatological Conditions .............................................................................................................134
WQ WQ WQ
Chapter 36. Diabetes Management .....................................................................................................................138
WQ WQ WQ
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer-Disease ........................................................................146
WQ WQ WQ WQ WQ WQ
Chapter 38. Headaches .......................................................................................................................................149
WQ WQ
Chapter 39. Heart Failure ...................................................................................................................................153
WQ WQ WQ
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ..............................................................158
WQ WQ WQ WQ WQ WQ WQ
Chapter 41. Menopausal Hormone Therapy .......................................................................................................161
WQ WQ WQ WQ
,Chapter 42. Hyperlipidemia................................................................................................................................164
WQ WQ
Chapter 43. Hypertension ...................................................................................................................................169
WQ WQ
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................174
WQ WQ WQ WQ
Chapter 45. Obesity ............................................................................................................................................177
WQ WQ
Chapter 46. Pain Management: Acute and Chronic Pain ....................................................................................181
WQ WQ WQ WQ WQ WQ WQ
Chapter 47. Pneumonia .......................................................................................................................................185
WQ WQ
Chapter 48. Sexually Transmitted Diseases and Vaginitis ..................................................................................187
WQ WQ WQ WQ WQ WQ
Chapter 49. Substance Use Disorders .................................................................................................................190
WQ WQ WQ WQ
Chapter 50. Tuberculosis ....................................................................................................................................195
WQ WQ
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .............197
W
Q WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 52. Urinary Tract Infections ..................................................................................................................200
WQ WQ WQ WQ
Chapter 53. Women as Patients ..........................................................................................................................203
WQ WQ WQ WQ
Chapter 54. Men as Patients................................................................................................................................207
WQ WQ WQ WQ
Chapter 55. Pediatric Patients .............................................................................................................................209
WQ WQ WQ
Chapter 57. Geriatric Patients .............................................................................................................................213
WQ WQ WQ
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 WQ WQ WQ WQ Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
MULTIPLE CHOICE WQ
1. Nurse practitioner-prescriptive authority is regulated by:
WQ WQ WQ WQ WQ
A. The National Council of State Boards of Nursing
WQ WQ WQ WQ WQ WQ WQ
B. The U.S. Drug Enforcement Administration
WQ WQ WQ WQ
C. The State Board of Nursing for each state
WQ WQ WQ WQ WQ WQ WQ
D. The State Board of Pharmacy
WQ WQ WQ WQ
ANS: C W Q PTS: W Q 1
2. The-benefits to the patient of having an advanced practice-
WQ WQ WQ WQ WQ WQ WQ WQ
registered nurse (APRN) prescriber include:
WQ WQ WQ WQ
A. Nurses know- WQ
more about pharmacology than other prescribers because they take it both in their
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
basic nursing program and in their APRN program.
WQ WQ WQ WQ WQ WQ WQ
B. Nurses care for the patient from a holistic approach and include the patient in
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
decision-making regarding their care. WQ WQ WQ
C. APRNs are less likely-to prescribe narcotics and other-controlled substances.
WQ WQ WQ WQ WQ WQ WQ W
Q
D. APRNs are able to prescribe- WQ WQ WQ WQ
independently in all states, whereas a physician’s assistant needs to have a ph WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
ysician supervising their practice. WQ WQ WQ
ANS: B W Q PTS: W Q 1
3. Clinical judgment in prescribing includes:
WQ WQ WQ WQ
A. Factoring in the cost to the patient of the medication prescribed
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
B. Always prescribing the newest medication available for the disease process
WQ WQ WQ WQ WQ WQ WQ WQ W
Q
C. Handing-out drug samples to poor patients WQ WQ WQ WQ WQ
D. Prescribing all generic medications to cut costs WQ WQ WQ WQ WQ WQ
ANS: A W Q PTS: W Q 1
4. The process for choosing an effective drug for a disorder-includes:
WQ WQ WQ WQ WQ WQ WQ WQ WQ
A. Asking the patient what drug they think would work best for-them
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
B. Consulting nationally-recognized guidelines for disease management
WQ WQ WQ WQ W
Q
C. Prescribing medications that are available as samples before writing a prescription
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
D. Following-U.S. Drug-Enforcement Administration guidelines for prescribing WQ WQ WQ WQ W
Q
ANS: B W Q PTS: W Q 1
5. Nonintentional nonadherence of drug therapy may occur-due to: WQ WQ WQ WQ WQ WQ WQ
A. Belief-that medication does not work WQ WQ WQ WQ
B. Adverse drug reactions WQ WQ
C. Chronic conditions that require daily therapy
WQ WQ WQ WQ WQ
D. Forgetfulness or distraction WQ W
Q
ANS: D W Q PTS: W Q 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy-L. Wright
, TABLE OF CONTENTWQ WQ
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................4
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 2. Review of Basic Principles of Pharmacology........................................................................................5
WQ WQ WQ WQ WQ WQ WQ
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
WQ WQ WQ WQ
Chapter 4. Legal and Professional Issues in Prescribing ...................................................................................... 14
WQ WQ WQ WQ WQ WQ WQ
Chapter 5. Adverse Drug Reactions..................................................................................................................... 16
WQ WQ WQ WQ
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
WQ WQ WQ WQ WQ
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
WQ WQ WQ WQ
Chapter 8. Herbal Therapies ................................................................................................................................ 28
WQ WQ WQ
Chapter 9. Cannabis ............................................................................................................................................. 31
WQ WQ
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
WQ WQ
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................ 38
WQ WQ WQ WQ WQ WQ WQ
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
WQ WQ WQ WQ WQ WQ WQ
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................. 53
WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 14. Drugs Affecting the Respiratory System .......................................................................................... 61
WQ WQ WQ WQ WQ WQ
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
WQ WQ WQ WQ WQ WQ
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................... 69
WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 17. Drugs Affecting the Immune System: Immunomodulators .............................................................. 75
WQ WQ WQ WQ WQ WQ WQ
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
WQ WQ WQ WQ WQ WQ
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .................... 80
W
Q WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs .............................. 83
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
WQ WQ WQ WQ WQ WQ
Chapter 22. Drugs Affecting the Bones and Joints .............................................................................................. 92
WQ WQ WQ WQ WQ WQ WQ
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
WQ WQ WQ WQ WQ WQ
Chapter 24. Drugs Used to Treat Bacterial Infections.........................................................................................101
WQ WQ WQ WQ WQ WQ WQ
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..........................................................105
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................108
WQ WQ WQ WQ WQ WQ WQ
Chapter 27. Drugs Used to Treat Eye and Ear-Disorders ....................................................................................111
WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 28. Anemia ............................................................................................................................................113
WQ WQ
Chapter 29. Anxiety and Depression ..................................................................................................................116
WQ WQ WQ WQ
Chapter 30. Attention Deficit-Hyperactivity-Disorder........................................................................................120
WQ WQ WQ
Chapter 31. Asthma and Allergy ........................................................................................................................122
WQ WQ WQ WQ
Chapter 32. Chronic Obstructive Pulmonary-Disease.........................................................................................125
WQ WQ WQ WQ
Chapter 33. Contraception ..................................................................................................................................127
WQ WQ
Chapter 34. COVID-19: Acute and Chronic .......................................................................................................130
WQ WQ WQ WQ WQ
Chapter 35. Dermatological Conditions .............................................................................................................134
WQ WQ WQ
Chapter 36. Diabetes Management .....................................................................................................................138
WQ WQ WQ
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer-Disease ........................................................................146
WQ WQ WQ WQ WQ WQ
Chapter 38. Headaches .......................................................................................................................................149
WQ WQ
Chapter 39. Heart Failure ...................................................................................................................................153
WQ WQ WQ
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ..............................................................158
WQ WQ WQ WQ WQ WQ WQ
Chapter 41. Menopausal Hormone Therapy .......................................................................................................161
WQ WQ WQ WQ
,Chapter 42. Hyperlipidemia................................................................................................................................164
WQ WQ
Chapter 43. Hypertension ...................................................................................................................................169
WQ WQ
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................174
WQ WQ WQ WQ
Chapter 45. Obesity ............................................................................................................................................177
WQ WQ
Chapter 46. Pain Management: Acute and Chronic Pain ....................................................................................181
WQ WQ WQ WQ WQ WQ WQ
Chapter 47. Pneumonia .......................................................................................................................................185
WQ WQ
Chapter 48. Sexually Transmitted Diseases and Vaginitis ..................................................................................187
WQ WQ WQ WQ WQ WQ
Chapter 49. Substance Use Disorders .................................................................................................................190
WQ WQ WQ WQ
Chapter 50. Tuberculosis ....................................................................................................................................195
WQ WQ
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .............197
W
Q WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
Chapter 52. Urinary Tract Infections ..................................................................................................................200
WQ WQ WQ WQ
Chapter 53. Women as Patients ..........................................................................................................................203
WQ WQ WQ WQ
Chapter 54. Men as Patients................................................................................................................................207
WQ WQ WQ WQ
Chapter 55. Pediatric Patients .............................................................................................................................209
WQ WQ WQ
Chapter 57. Geriatric Patients .............................................................................................................................213
WQ WQ WQ
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 WQ WQ WQ WQ Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
MULTIPLE CHOICE WQ
1. Nurse practitioner-prescriptive authority is regulated by:
WQ WQ WQ WQ WQ
A. The National Council of State Boards of Nursing
WQ WQ WQ WQ WQ WQ WQ
B. The U.S. Drug Enforcement Administration
WQ WQ WQ WQ
C. The State Board of Nursing for each state
WQ WQ WQ WQ WQ WQ WQ
D. The State Board of Pharmacy
WQ WQ WQ WQ
ANS: C W Q PTS: W Q 1
2. The-benefits to the patient of having an advanced practice-
WQ WQ WQ WQ WQ WQ WQ WQ
registered nurse (APRN) prescriber include:
WQ WQ WQ WQ
A. Nurses know- WQ
more about pharmacology than other prescribers because they take it both in their
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
basic nursing program and in their APRN program.
WQ WQ WQ WQ WQ WQ WQ
B. Nurses care for the patient from a holistic approach and include the patient in
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
decision-making regarding their care. WQ WQ WQ
C. APRNs are less likely-to prescribe narcotics and other-controlled substances.
WQ WQ WQ WQ WQ WQ WQ W
Q
D. APRNs are able to prescribe- WQ WQ WQ WQ
independently in all states, whereas a physician’s assistant needs to have a ph WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
ysician supervising their practice. WQ WQ WQ
ANS: B W Q PTS: W Q 1
3. Clinical judgment in prescribing includes:
WQ WQ WQ WQ
A. Factoring in the cost to the patient of the medication prescribed
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
B. Always prescribing the newest medication available for the disease process
WQ WQ WQ WQ WQ WQ WQ WQ W
Q
C. Handing-out drug samples to poor patients WQ WQ WQ WQ WQ
D. Prescribing all generic medications to cut costs WQ WQ WQ WQ WQ WQ
ANS: A W Q PTS: W Q 1
4. The process for choosing an effective drug for a disorder-includes:
WQ WQ WQ WQ WQ WQ WQ WQ WQ
A. Asking the patient what drug they think would work best for-them
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
B. Consulting nationally-recognized guidelines for disease management
WQ WQ WQ WQ W
Q
C. Prescribing medications that are available as samples before writing a prescription
WQ WQ WQ WQ WQ WQ WQ WQ WQ WQ
D. Following-U.S. Drug-Enforcement Administration guidelines for prescribing WQ WQ WQ WQ W
Q
ANS: B W Q PTS: W Q 1
5. Nonintentional nonadherence of drug therapy may occur-due to: WQ WQ WQ WQ WQ WQ WQ
A. Belief-that medication does not work WQ WQ WQ WQ
B. Adverse drug reactions WQ WQ
C. Chronic conditions that require daily therapy
WQ WQ WQ WQ WQ
D. Forgetfulness or distraction WQ W
Q
ANS: D W Q PTS: W Q 1
